Andrew Lassman, MD

John Harris Associate Professor of Neurology and the Chief of Neuro-oncology at Columbia University Irving Medical Center and the Associate Director for Clinical Trials at the Herbert Irving Comprehensive Cancer Center

Dr. Lassman is a neuro-oncologist whose research and clinical efforts focus on improving the understanding and treatment of brain tumors. Specifically, his research interests focus on translational clinical trials for brain tumors with molecular correlative analyses to understand the reasons for treatment success or failure, and to refine treatment paradigms. Dr. Lassman has led retrospective studies, single institution prospective clinical trials, and multicenter prospective trials conducted nationally through the National Cancer Institute sponsored National Clinical Trials Network. His contributions to the field of neuro-oncology has been recognized with numerous awards, including the Preuss Award in Neuro-Oncology from the American Academy of Neurology, the Boyer Clinical Research Award from Memorial Sloan-Kettering Cancer Center, and the Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer.

Dr. Lassman earned his BS and MS degrees in Molecular Biophysics and Biochemistry as part of a combined 4-year program at Yale University, and went on to receive his MD from Columbia University College of Physicians and Surgeons. Dr. Lassman subsequently completed his residency at the Neurological Institute of New York-Presbyterian Hospital/Columbia University Irving Medical Center, and fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center, where he then joined the faculty and served as fellowship director.